Advanced Therapies Europe | Cell & Gene Therapy Event in Barcelona

Super Early Bird Passes - SOLD OUT
Early Bird - SOLD OUT
Standard Pricing Available

Limited to 500 places, apply to attend before 2nd September to save up to *£500 per ticket

Apply Now - Limited Tickets Available

500

Attendees

30+

Countries

50+

Speakers

170+

Therapeutic Developers

Curated. Connected. Designed for impact.

Now in its 5th year, Advanced Therapies Europe 2025 is an intentionally intimate event — limited to just 500 senior-level decision-makers — to ensure every conversation drives outcomes. Held in Barcelona, at the heart of Europe’s fast-growing biotech ecosystem, this is where strategic connections ignite progress and insights lead to action. Whether you're here to invest, scale, partner, or launch, ATE 2025 gives you the platform to make it happen.

Sponsor With Us Secure Your Place

Meet the speakers

Apply to Speak

Alessandra Magnani

Head of the Advanced Therapies and Immunotherapy Platform
Alexander Natz

Secretary General
Angela Vollstedt

Director Global Cell & Gene Therapies Portfolio
Anna Koptina

Head of Regulatory Affairs
Anna Malinowska

Lead Regulatory Strategist
Anne Douar

Principal & Founder
Anni Moro

Co-founder & CEO

Anni Mörö is Founder and COO of StemSight. StemSight is a pre-clinical stage biopharma company developing proprietary hypoimmunoge ...
Armin Nowack

Senior Vice President Business Development

Armin Nowack is SVP Business Development of Swissfinity Group, a European investment company in the advanced biotech sector. Arm ...
Artemy Shumisky

Senior Associate

Artemy Shumskiy is a Senior Associate at LongeVC, where he leverages his scientific expertise in molecular, computational, and agi ...
Åse Rosenqvist

Nordic Cell Therapy Business Unit Lead
Avencia Sanchez-Mejias

CEO & Co-founder
Benjamin Dewees

Senior Vice President of Regulatory Affairs
Bernd Schmidt

Chief Technical Officer
Bruno Montanari

Partner

Bruno Montanari is a Paris-based Partner at Seroba which he joined late 2017. He has a background in venture capital and in invest ...
Carmen Sanges

Scientific and Strategic Project Manager
Carolina Pola

CEO
Chris Barkey

CEO
Claire Skentelbery

Director General
Damian Marshall

VP Analytical Development
David Sourdive

Co-founder, Executive Vice President CMC & Manufacturing

Event accreditation

Advanced Therapies Europe 2025 has been officially accredited by The CPD Group, the UK’s largest and most trusted continuing professional development accreditation body. This recognition reflects the exceptional educational value of our agenda, speakers, and scientific content.

By attending ATE, you’ll not only gain access to high-level insights from across the advanced therapies landscape — you'll also be able to:

Earn CPD credits recognised by employers and professional bodies
Receive a certificate of attendance at no additional cost
Demonstrate your ongoing commitment to industry excellence

Whether you're attending to stay ahead of regulatory changes, deepen your scientific understanding, or expand your commercial skillset, your time at ATE counts toward your professional growth.

Learn More

Apply to attend – Only 500 passes available

Attendance at Advanced Therapies Europe 2025 is limited to just 500 qualified delegates. Whether you're driving investment, scaling manufacturing, or building your next therapeutic breakthrough, your experience will be tailored, targeted, and designed for maximum impact.

Super Early Bird - SOLD OUT!
Early Bird - SOLD OUT!

Standard Pricing Available — apply now to secure your place at Europe’s premier cell and gene therapy event.